Abstract | AIMS: To assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of intranasal SB-705498, a selective TRPV1 antagonist. METHODS: Two randomized, double-blind, placebo-controlled, clinical studies were performed: (i) an intranasal SB-705498 first time in human study to examine the safety and PK of five single escalating doses from 0.5 to 12 mg and of repeat dosing with 6 mg and 12 mg twice daily for 14 days and (ii) a PD efficacy study in subjects with non- allergic rhinitis (NAR) to evaluate the effect of 12 mg intranasal SB-705498 against nasal capsaicin challenge. RESULTS: Single and repeat dosing with intranasal SB-705498 was safe and well tolerated. The overall frequency of adverse events was similar for SB-705498 and placebo and no dose-dependent increase was observed. Administration of SB-705498 resulted in less than dose proportional AUC(0,12 h) and Cmax , while repeat dosing from day 1 to day 14 led to its accumulation. SB-705498 receptor occupancy in nasal tissue was estimated to be high (>80%). Administration of 12 mg SB-705498 to patients with NAR induced a marked reduction in total symptom scores triggered by nasal capsaicin challenge. Inhibition of rhinorrhoea, nasal congestion and burning sensation was associated with 2- to 4-fold shift in capsaicin potency. CONCLUSIONS: Intranasal SB-705498 has an appropriate safety and PK profile for development in humans and achieves clinically relevant attenuation of capsaicin-provoked rhinitis symptoms in patients with NAR. The potential impact intranasal SB-705498 may have in rhinitis treatment deserves further evaluation.
|
Authors | Carlijn Holland, Cornelis van Drunen, Jane Denyer, Kevin Smart, Christine Segboer, Ingrid Terreehorst, Amy Newlands, Misba Beerahee, Wytske Fokkens, Daphne C Tsitoura |
Journal | British journal of clinical pharmacology
(Br J Clin Pharmacol)
Vol. 77
Issue 5
Pg. 777-88
(May 2014)
ISSN: 1365-2125 [Electronic] England |
PMID | 23909699
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 The British Pharmacological Society. |
Chemical References |
- Pyrrolidines
- SB 705498
- TRPV Cation Channels
- TRPV1 receptor
- Urea
- Capsaicin
|
Topics |
- Adolescent
- Adult
- Capsaicin
(antagonists & inhibitors)
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Pyrrolidines
(adverse effects, pharmacokinetics, pharmacology)
- Rhinitis
(drug therapy)
- TRPV Cation Channels
(antagonists & inhibitors)
- Urea
(adverse effects, analogs & derivatives, pharmacokinetics, pharmacology)
- Visual Analog Scale
|